Sunday, April 17, 2011
Lilly, Amylin diabetes drug wins EU recommendation - Reuters
ThirdAgeLilly, Amylin diabetes drug wins EU recommendationReutersLONDON, April 15 (Reuters) - An experimental diabetes medicine from Eli Lilly (LLY.N) and Amylin Pharmaceuticals (AMLN.O), that patients need to inject only once a week, has been recommended for approval by European regulators. ...EU Gives Support To Eli Lilly, Amylin Diabetes DrugSmartAboutHealthPharma News: Lilly, Amylin & Alkermes Get European Nod; Pfizer Announced ...ForbesAmlyn, Alkermes Shares Gain As EMA Committee
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment